Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Kyle Molina

Concepts (155)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anti-Bacterial Agents
21
2026
1942
2.700
Why?
Vancomycin
8
2025
96
1.820
Why?
Osteomyelitis
2
2025
148
1.530
Why?
Gram-Positive Bacterial Infections
3
2025
72
1.190
Why?
Outpatients
5
2024
440
1.080
Why?
Adenosine Monophosphate
2
2025
87
1.000
Why?
Alanine
2
2025
171
0.980
Why?
Tetracyclines
5
2026
16
0.940
Why?
Vancomycin-Resistant Enterococci
2
2025
9
0.940
Why?
Enterococcus faecium
2
2025
22
0.920
Why?
Teicoplanin
2
2021
15
0.850
Why?
Arthritis, Infectious
1
2025
77
0.800
Why?
Ritonavir
2
2023
76
0.780
Why?
Antiviral Agents
4
2025
779
0.750
Why?
Organ Transplantation
2
2024
244
0.720
Why?
beta-Lactamases
1
2022
54
0.690
Why?
Invasive Fungal Infections
1
2021
12
0.670
Why?
Aspergillosis
1
2021
24
0.670
Why?
Candidiasis
1
2021
64
0.650
Why?
Cephalosporins
4
2026
45
0.640
Why?
Microbial Sensitivity Tests
7
2026
367
0.630
Why?
Methicillin-Resistant Staphylococcus aureus
2
2021
253
0.630
Why?
Staphylococcal Infections
2
2021
397
0.580
Why?
Acute Kidney Injury
3
2024
866
0.550
Why?
Blood Coagulation Factors
1
2018
71
0.520
Why?
Hospitalization
5
2025
2475
0.490
Why?
Retrospective Studies
19
2026
17438
0.410
Why?
Sepsis
1
2020
669
0.390
Why?
Hemorrhage
1
2018
825
0.370
Why?
Kidney
2
2023
1498
0.370
Why?
Critical Illness
1
2019
908
0.360
Why?
Treatment Outcome
9
2026
11821
0.340
Why?
Humans
36
2026
146342
0.330
Why?
Drug-Related Side Effects and Adverse Reactions
2
2024
266
0.320
Why?
Wounds and Injuries
1
2019
959
0.320
Why?
Antibodies, Viral
2
2024
689
0.290
Why?
Aged
14
2026
26432
0.280
Why?
Drug Resistance, Multiple, Bacterial
5
2026
77
0.250
Why?
Immunocompromised Host
2
2025
201
0.250
Why?
Adult
15
2026
41087
0.240
Why?
Ceftazidime
1
2026
8
0.240
Why?
Azabicyclo Compounds
1
2026
9
0.240
Why?
Middle Aged
13
2026
36619
0.230
Why?
Gram-Negative Bacterial Infections
1
2026
50
0.230
Why?
Escherichia coli Infections
1
2026
125
0.220
Why?
Observational Studies as Topic
1
2025
133
0.220
Why?
Pseudomonas aeruginosa
2
2026
392
0.210
Why?
Pyoderma Gangrenosum
1
2024
8
0.210
Why?
Cytomegalovirus Retinitis
1
2024
22
0.210
Why?
Recurrence
2
2025
1133
0.210
Why?
Health Care Rationing
1
2024
54
0.200
Why?
Cystitis
1
2024
24
0.200
Why?
Aminoglycosides
1
2024
29
0.200
Why?
Bacterial Infections
1
2026
247
0.200
Why?
beta-Lactams
2
2023
34
0.200
Why?
Endocarditis, Bacterial
1
2024
46
0.200
Why?
Endocarditis
1
2024
40
0.190
Why?
Immune Reconstitution
1
2023
10
0.190
Why?
Antibodies, Neutralizing
2
2023
348
0.190
Why?
Lactams
1
2023
28
0.190
Why?
Drug Therapy, Combination
3
2023
1036
0.190
Why?
Acinetobacter Infections
1
2022
15
0.190
Why?
Acinetobacter baumannii
1
2022
26
0.180
Why?
Proline
1
2023
79
0.180
Why?
Leucine
1
2023
116
0.180
Why?
Male
16
2026
73396
0.180
Why?
Antibodies, Monoclonal
3
2024
1512
0.180
Why?
Cord Blood Stem Cell Transplantation
1
2023
103
0.180
Why?
Pseudomonas Infections
1
2024
229
0.180
Why?
Mycobacterium abscessus
1
2023
110
0.170
Why?
Klebsiella pneumoniae
1
2022
48
0.170
Why?
Nitriles
1
2023
212
0.170
Why?
Escherichia coli
1
2026
832
0.170
Why?
Creatinine
2
2023
511
0.170
Why?
Renal Insufficiency
1
2023
173
0.170
Why?
Cytomegalovirus Infections
1
2023
206
0.170
Why?
Clostridium Infections
1
2022
75
0.170
Why?
Daptomycin
1
2021
18
0.170
Why?
Female
15
2026
79499
0.160
Why?
Plasmids
1
2022
373
0.160
Why?
Antifungal Agents
1
2021
153
0.160
Why?
Colorado
3
2025
4595
0.150
Why?
Salvage Therapy
1
2021
166
0.150
Why?
Mycobacterium Infections, Nontuberculous
1
2023
339
0.140
Why?
Burns
1
2023
365
0.140
Why?
Machine Learning
1
2024
594
0.140
Why?
Vitamin K
1
2018
46
0.140
Why?
Hemostatics
1
2018
66
0.130
Why?
Isoantibodies
1
2017
58
0.130
Why?
Bacteremia
3
2026
218
0.130
Why?
Hematopoietic Stem Cell Transplantation
1
2023
704
0.130
Why?
Renal Insufficiency, Chronic
1
2023
640
0.120
Why?
HLA Antigens
1
2017
241
0.120
Why?
Severity of Illness Index
2
2024
2921
0.110
Why?
Bacterial Proteins
1
2022
980
0.110
Why?
Graft Survival
1
2017
523
0.110
Why?
Graft Rejection
1
2017
516
0.100
Why?
Logistic Models
1
2019
2126
0.100
Why?
Cystic Fibrosis
1
2023
1164
0.100
Why?
Intensive Care Units
1
2019
925
0.090
Why?
Transplant Recipients
2
2024
177
0.090
Why?
Emergency Service, Hospital
1
2024
2363
0.090
Why?
Risk Factors
3
2024
10921
0.080
Why?
Heart Transplantation
1
2017
682
0.080
Why?
Standard of Care
2
2022
81
0.080
Why?
Quality of Life
1
2021
3200
0.070
Why?
Cefotaxime
1
2026
3
0.060
Why?
Skin Diseases, Bacterial
1
2026
22
0.060
Why?
Ceftriaxone
1
2026
21
0.060
Why?
Cefazolin
1
2026
22
0.060
Why?
Enterococcus faecalis
1
2025
29
0.060
Why?
Utah
1
2025
82
0.060
Why?
Drug Combinations
1
2026
400
0.050
Why?
Subcutaneous Tissue
1
2024
26
0.050
Why?
Skin Transplantation
1
2024
77
0.050
Why?
United States Food and Drug Administration
1
2024
208
0.050
Why?
Viremia
1
2024
158
0.050
Why?
Gram-Negative Bacteria
1
2023
80
0.050
Why?
Piperacillin
1
2023
7
0.050
Why?
Administration, Oral
1
2026
872
0.050
Why?
Acetates
1
2023
78
0.050
Why?
Carbapenems
1
2022
28
0.050
Why?
Minocycline
1
2022
23
0.050
Why?
Cytomegalovirus
1
2023
172
0.040
Why?
Proportional Hazards Models
1
2025
1331
0.040
Why?
Quinazolines
1
2023
267
0.040
Why?
Nontuberculous Mycobacteria
1
2023
189
0.040
Why?
Treatment Failure
1
2022
361
0.040
Why?
Bone and Bones
1
2024
319
0.040
Why?
Health Policy
1
2024
399
0.040
Why?
Gentamicins
1
2021
50
0.040
Why?
Hospital Mortality
1
2025
1051
0.040
Why?
Rifampin
1
2021
80
0.040
Why?
Drug Synergism
1
2021
354
0.040
Why?
Glomerular Filtration Rate
1
2023
745
0.040
Why?
Skin
1
2024
701
0.040
Why?
Delayed-Action Preparations
1
2020
192
0.040
Why?
United States
2
2026
16136
0.030
Why?
Incidence
1
2024
2936
0.030
Why?
Electronic Health Records
1
2024
1210
0.030
Why?
Kaplan-Meier Estimate
1
2017
970
0.030
Why?
Multivariate Analysis
1
2017
1543
0.030
Why?
Flow Cytometry
1
2017
1163
0.020
Why?
Aged, 80 and over
1
2025
8391
0.020
Why?
Adolescent
2
2024
22557
0.020
Why?
Databases, Factual
1
2017
1493
0.020
Why?
Prospective Studies
1
2024
8123
0.020
Why?
Obesity
1
2022
3131
0.020
Why?
Registries
1
2017
2400
0.020
Why?
Young Adult
1
2024
14330
0.020
Why?
Biomarkers
1
2017
4340
0.010
Why?
Infant, Newborn
1
2017
6460
0.010
Why?
Infant
1
2017
10114
0.010
Why?
Child, Preschool
1
2017
11913
0.010
Why?
Child
1
2017
22693
0.010
Why?
Molina's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)